Suppr超能文献

DCAF11 通过亲电蛋白水解靶向嵌合体支持靶向蛋白降解。

DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras.

机构信息

The Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92307, United States.

Vividion Therapeutics, 5820 Nancy Ridge Dr, San Diego, California 92121, United States.

出版信息

J Am Chem Soc. 2021 Apr 7;143(13):5141-5149. doi: 10.1021/jacs.1c00990. Epub 2021 Mar 30.

Abstract

Ligand-induced protein degradation has emerged as a compelling approach to promote the targeted elimination of proteins from cells by directing these proteins to the ubiquitin-proteasome machinery. So far, only a limited number of E3 ligases have been found to support ligand-induced protein degradation, reflecting a dearth of E3-binding compounds for proteolysis-targeting chimera (PROTAC) design. Here, we describe a functional screening strategy performed with a focused library of candidate electrophilic PROTACs to discover bifunctional compounds that degrade proteins in human cells by covalently engaging E3 ligases. Mechanistic studies revealed that the electrophilic PROTACs act through modifying specific cysteines in DCAF11, a poorly characterized E3 ligase substrate adaptor. We further show that DCAF11-directed electrophilic PROTACs can degrade multiple endogenous proteins, including FBKP12 and the androgen receptor, in human prostate cancer cells. Our findings designate DCAF11 as an E3 ligase capable of supporting ligand-induced protein degradation via electrophilic PROTACs.

摘要

配体诱导的蛋白质降解已成为一种引人注目的方法,可以通过将这些蛋白质定向到泛素蛋白酶体机制来促进细胞中蛋白质的靶向消除。到目前为止,仅发现少数 E3 连接酶能够支持配体诱导的蛋白质降解,这反映了用于蛋白水解靶向嵌合体(PROTAC)设计的 E3 结合化合物的缺乏。在这里,我们描述了一种使用候选亲电子 PROTAC 的重点文库进行的功能筛选策略,以发现通过共价结合 E3 连接酶降解人细胞中蛋白质的双功能化合物。机制研究表明,亲电子 PROTAC 通过修饰 DCAF11 中的特定半胱氨酸起作用,DCAF11 是一种 poorly characterized E3 连接酶底物衔接子。我们进一步表明,DCAF11 定向亲电子 PROTAC 可以降解人前列腺癌细胞中的多种内源性蛋白质,包括 FBKP12 和雄激素受体。我们的研究结果将 DCAF11 指定为一种 E3 连接酶,能够通过亲电子 PROTAC 支持配体诱导的蛋白质降解。

相似文献

5
Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16.通过结合 DCAF16 降解核蛋白的亲电 PROTAC 分子。
Nat Chem Biol. 2019 Jul;15(7):737-746. doi: 10.1038/s41589-019-0279-5. Epub 2019 Jun 17.
6
Synthesis and biological evaluation of niclosamide PROTACs.尼氯硝唑类蛋白水解靶向嵌合体的合成与生物评价。
Bioorg Med Chem Lett. 2022 Sep 15;72:128870. doi: 10.1016/j.bmcl.2022.128870. Epub 2022 Jun 27.
9
Targeted protein degradation via intramolecular bivalent glues.通过分子内双价胶实现靶向蛋白降解。
Nature. 2024 Mar;627(8002):204-211. doi: 10.1038/s41586-024-07089-6. Epub 2024 Feb 21.
10
Targeted Protein Degradation through E2 Recruitment.通过 E2 招募实现靶向蛋白降解。
ACS Chem Biol. 2023 Apr 21;18(4):897-904. doi: 10.1021/acschembio.3c00040. Epub 2023 Mar 20.

引用本文的文献

1
DCAF16-Based Covalent Degradative Handles for the Modular Design of Degraders.基于DCAF16的共价降解手柄用于降解剂的模块化设计。
ACS Cent Sci. 2025 Jun 26;11(7):1207-1217. doi: 10.1021/acscentsci.5c00959. eCollection 2025 Jul 23.
2
Advancing Design Strategy of PROTACs for Cancer Therapy.用于癌症治疗的PROTACs的先进设计策略
MedComm (2020). 2025 Jun 25;6(7):e70258. doi: 10.1002/mco2.70258. eCollection 2025 Jul.
10
Discovery of DCAF16 Binders for Targeted Protein Degradation.用于靶向蛋白质降解的DCAF16结合剂的发现。
ACS Chem Biol. 2025 Feb 21;20(2):479-488. doi: 10.1021/acschembio.4c00799. Epub 2025 Jan 30.

本文引用的文献

8
Targeted protein degradation: expanding the toolbox.靶向蛋白降解:拓展工具盒。
Nat Rev Drug Discov. 2019 Dec;18(12):949-963. doi: 10.1038/s41573-019-0047-y. Epub 2019 Oct 30.
9
Development of targeted protein degradation therapeutics.靶向蛋白降解治疗药物的研发。
Nat Chem Biol. 2019 Oct;15(10):937-944. doi: 10.1038/s41589-019-0362-y. Epub 2019 Sep 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验